Neoaskofenas (Paracetamol, Acetylsalicylic Acid, Caffeine)

Neoaskofenas combines analgesic and antipyretic agents that act on prostaglandin pathways to alleviate pain and reduce fever in a variety of acute conditions.

• Headache: provides relief of mild to moderate headache pain.
• Migraine: helps reduce migraine‑associated pain when combined with caffeine.
• General pain: alleviates musculoskeletal or dental pain.
• Fever: lowers elevated body temperature in febrile conditions.
• Cold symptoms: eases discomfort associated with common cold.

• Paracetamol acts as a central cyclo‑oxygenase (COX) inhibitor, reducing prostaglandin synthesis in the brain to produce analgesic and antipyretic effects. Acetylsalicylic acid irreversibly inhibits COX‑1 and COX‑2 in peripheral tissues, decreasing prostaglandin formation and providing anti‑inflammatory and analgesic activity. Caffeine antagonizes adenosine receptors, enhancing central nervous system stimulation and increasing the overall analgesic potency of the other two components in the combined formulation.

Neoaskofenas may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea: mild stomach upset often occurring after ingestion.
• Gastric discomfort: transient abdominal pain or indigestion.
• Insomnia: difficulty falling or staying asleep, especially due to caffeine.
• Headache: paradoxical headache in susceptible individuals.
• Dizziness: light‑headed sensation without loss of balance.

Serious or Rare Side Effects

• Allergic reactions: rash, itching, swelling, or anaphylaxis.
• Bleeding tendency: increased risk of gastrointestinal bleeding from aspirin component.
• Liver injury: elevated transaminases or hepatitis with excessive paracetamol exposure.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Renal impairment: reduced kidney function with prolonged high‑dose use.

Before using Neoaskofenas, consider the following precautions to minimize risks.

• Assess liver function: avoid use in patients with severe hepatic impairment.
• Evaluate bleeding risk: caution in individuals with ulcers, anticoagulant therapy, or clotting disorders.
• Monitor caffeine intake: limit additional caffeine sources to prevent overstimulation.
• Use in children: follow pediatric dosing guidelines and avoid exceeding recommended daily limits.
• Pregnancy and lactation: consult a healthcare professional before use during pregnancy or breastfeeding.
• Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Neoaskofenas can interact with several medicines; awareness of major and moderate interactions helps ensure safe use.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased bleeding risk due to aspirin component.
• Other NSAIDs: additive gastrointestinal toxicity and bleeding.
• High‑dose paracetamol products: risk of hepatotoxicity from cumulative dosing.
• Monoamine oxidase inhibitors: potential for hypertensive reactions with caffeine.
• Alcohol: enhances gastric irritation and liver toxicity.

Moderate Interactions (Monitor Closely)

• Corticosteroids: may increase risk of gastrointestinal ulceration.
• Selective serotonin reuptake inhibitors: slight increase in bleeding tendency.
• Diuretics: caffeine may reduce diuretic effectiveness.
• Anticonvulsants (e.g., carbamazepine): may lower plasma levels of paracetamol.
• Herbal supplements containing caffeine: may augment stimulant effects.